序号 |
标题 |
次数 |
作者 |
发布时间 |
81541 |
IRFE-PEG-DOTA(IPD), 近红外二区(NIR II)有机染料 |
160 |
wyh |
2024-12-03 |
81542 |
[18F]FN-PEG4-Tz-TCO-GK-PEG4-5F7 ([18F]FN-GK-5F7) |
109 |
WYQ |
2024-12-03 |
81543 |
64Cu]Cu-NOTA-PEG7-H-Tz |
126 |
WYQ |
2024-12-03 |
81544 |
DOTA-PEG-DSPE ,DOTA-聚乙二醇-磷脂 |
93 |
wyh |
2024-12-03 |
81545 |
3,6-二氨基-1,2,4,5-四嗪(DATZ) |
84 |
WYQ |
2024-12-03 |
81546 |
DOTA-PEG(4)-BBN ;DOTA-四聚乙二醇-铃蟾肽 |
85 |
wyh |
2024-12-03 |
81547 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
132 |
WYQ |
2024-12-03 |
81548 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
182 |
WYQ |
2024-12-03 |
81549 |
TCO-CC49 ,TCO功能化CC49抗体 |
115 |
wyh |
2024-12-03 |
81550 |
[111In]In-DOTA-PEG11-BisPy-Tz |
112 |
WYQ |
2024-12-03 |
81551 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
99 |
WYQ |
2024-12-03 |
81552 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
96 |
WYQ |
2024-12-03 |
81553 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
110 |
WYQ |
2024-12-03 |
81554 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
82 |
wyh |
2024-12-03 |
81555 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
115 |
WYQ |
2024-12-03 |
81556 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
127 |
WYQ |
2024-12-03 |
81557 |
[64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 |
195 |
WYQ |
2024-12-03 |
81558 |
DOTA-monoamide,DOTA-单酰胺复合物 |
99 |
wyh |
2024-12-03 |
81559 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
150 |
wyh |
2024-12-03 |
81560 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
105 |
wyh |
2024-12-03 |
81561 |
甲氧基DOTA ,MeO-DOTA |
198 |
wyh |
2024-12-03 |
81562 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
187 |
wyh |
2024-12-03 |
81563 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
106 |
wyh |
2024-12-03 |
81564 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
103 |
wyh |
2024-12-03 |
81565 |
DOTA-GA,螯合剂DOTA肽缀合物 |
130 |
wyh |
2024-12-03 |
81566 |
DOTA共轭二膦酸盐,DOTA-HBP |
117 |
wyh |
2024-12-03 |
81567 |
DOTA-神经介素n ,DOTA-Neuromedin N |
105 |
wyh |
2024-12-03 |
81568 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
86 |
wyh |
2024-12-03 |
81569 |
6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine |
105 |
WYQ |
2024-12-03 |
81570 |
6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
128 |
WYQ |
2024-12-03 |
81571 |
cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA |
74 |
wyh |
2024-12-03 |
81572 |
6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine |
109 |
WYQ |
2024-12-03 |
81573 |
MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 |
134 |
wyh |
2024-12-03 |
81574 |
DOTA-BR96 ,DOTA标记BR96单克隆抗体 |
108 |
wyh |
2024-12-03 |
81575 |
DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA |
94 |
wyh |
2024-12-03 |
81576 |
DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 |
97 |
wyh |
2024-12-03 |
81577 |
3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine |
108 |
WYQ |
2024-12-03 |
81578 |
3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) |
186 |
WYQ |
2024-12-03 |
81579 |
c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 |
103 |
wyh |
2024-12-03 |
81580 |
3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) |
112 |
WYQ |
2024-12-03 |
81581 |
3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine |
124 |
WYQ |
2024-12-03 |
81582 |
3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine |
126 |
WYQ |
2024-12-03 |
81583 |
3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) |
154 |
WYQ |
2024-12-03 |
81584 |
3,6-d二肼基-1,2,4,5-四嗪(DHT) |
113 |
WYQ |
2024-12-03 |
81585 |
DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE |
92 |
wyh |
2024-12-03 |